NCT05167721View on ClinicalTrials.gov

Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Multiple System Atrophy
Interventions
BIOLOGICAL

Autologous Mesenchymal Stem Cells

Autologous Mesenchymal Stem Cells administered intrathecally

OTHER

Placebo

Placebo administered intrathecally

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05167721 - Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy | Biotech Hunter | Biotech Hunter